Production & Manufacturing
Fine & Speciality Chemicals

Peptides and Oligonucleotides

Published 19 February 2014 | By Sanofi CEPiA

From a unique state-of-the-art platform for development and scale-up of Peptides and Oligonucleotides, CEPiA offers customised manufacturing and analytical services and development activities from clinical phase, up to submission and launch, as well as regulatory support and commercial supplies.

Available Downloads

Peptides and Oligonucleotides